
ALT The SPIRO-AID study The purpose of the SPIRO-AID study is to evaluate whether an Artificial Intelligence (AI) decision support software (ArtiQ.Spiro) improves the diagnostic accuracy and quality assessment of spirometry by primary care clinicians. What is the reason for this study? Lung disease is the third biggest cause of death in the UK. It is a national health priority in The NHS Long Term Plan for England. Spirometry is a breathing test that measures how much air a person can breathe in and then empty their lungs. It is important for the diagnosis of common lung conditions. Sometimes it is difficult to perform good quality spirometry in the community and it can be difficult to interpret the results. ArtiQ.Spiro is an artificial intelligence (AI) software which has been developed to help with the quality assessment and interpretation of spirometry. This software has previously been tested and is currently used successfully in European hospitals. AI uses pattern recognition





















